JP2020524496A5 - - Google Patents

Download PDF

Info

Publication number
JP2020524496A5
JP2020524496A5 JP2019567572A JP2019567572A JP2020524496A5 JP 2020524496 A5 JP2020524496 A5 JP 2020524496A5 JP 2019567572 A JP2019567572 A JP 2019567572A JP 2019567572 A JP2019567572 A JP 2019567572A JP 2020524496 A5 JP2020524496 A5 JP 2020524496A5
Authority
JP
Japan
Prior art keywords
zikv
protein
seq
sequence
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2019567572A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020524496A (ja
Filing date
Publication date
Priority claimed from EP17305676.3A external-priority patent/EP3412307A1/en
Application filed filed Critical
Publication of JP2020524496A publication Critical patent/JP2020524496A/ja
Publication of JP2020524496A5 publication Critical patent/JP2020524496A5/ja
Priority to JP2023081004A priority Critical patent/JP2023107780A/ja
Ceased legal-status Critical Current

Links

JP2019567572A 2017-06-07 2018-06-06 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用 Ceased JP2020524496A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023081004A JP2023107780A (ja) 2017-06-07 2023-05-16 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17305676.3 2017-06-07
EP17305676.3A EP3412307A1 (en) 2017-06-07 2017-06-07 Recombinant measles virus expressing zika virus proteins and their applications
PCT/EP2018/064943 WO2018224573A1 (en) 2017-06-07 2018-06-06 Recombinant measles virus expressing zika virus proteins and their applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023081004A Division JP2023107780A (ja) 2017-06-07 2023-05-16 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用

Publications (2)

Publication Number Publication Date
JP2020524496A JP2020524496A (ja) 2020-08-20
JP2020524496A5 true JP2020524496A5 (enExample) 2021-07-26

Family

ID=59276634

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019567572A Ceased JP2020524496A (ja) 2017-06-07 2018-06-06 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用
JP2023081004A Pending JP2023107780A (ja) 2017-06-07 2023-05-16 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023081004A Pending JP2023107780A (ja) 2017-06-07 2023-05-16 ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用

Country Status (9)

Country Link
US (1) US11857616B2 (enExample)
EP (2) EP3412307A1 (enExample)
JP (2) JP2020524496A (enExample)
CN (1) CN110891600B (enExample)
AU (1) AU2018281889B2 (enExample)
BR (1) BR112019025310A2 (enExample)
CA (1) CA3064322A1 (enExample)
MX (1) MX2019014674A (enExample)
WO (1) WO2018224573A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3031923A1 (en) * 2014-12-11 2016-06-15 Institut Pasteur Lentiviral vector-based japanese encephalitis immunogenic composition
AU2017222644B2 (en) * 2016-02-25 2021-07-29 The Trustees Of The University Of Pennsylvania Novel vaccines against Zika virus
EP3412307A1 (en) * 2017-06-07 2018-12-12 Institut Pasteur Recombinant measles virus expressing zika virus proteins and their applications
KR101966841B1 (ko) * 2018-12-12 2019-04-08 대한민국 지카바이러스 e 단백질 유래의 재조합 항원 및 이의 용도
AU2020273263A1 (en) * 2019-04-10 2021-12-02 Katholieke Universiteit Leuven Chimeric Zika-Japanese encephalitis virus
CN113999823B (zh) * 2021-12-30 2022-04-26 北京赛尔富森生物科技有限公司 D8基因型嵌合麻疹病毒减毒株和制备方法及用途
JP2025510008A (ja) * 2022-02-22 2025-04-14 ヴァイロ バイオ インク． 外因性ポリヌクレオチドの送達のための核酸組成物および使用方法
EP4604993A2 (en) * 2022-10-21 2025-08-27 Institut Pasteur Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selected from the group of denv, zikv and yfv, inducing protective cd8+ t-cell immunity in a host

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1375512T3 (da) 2002-06-20 2009-10-26 Pasteur Institut Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger
ES2423518T3 (es) 2006-12-22 2013-09-20 Institut Pasteur Células y metodología para generar virus de ARN de cadena de sentido negativo no segmentada
EP2712871A1 (en) * 2012-09-27 2014-04-02 Institut Pasteur Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
US20180339038A1 (en) * 2015-06-12 2018-11-29 Mie University Human parainfluenza virus type 2 vector and vaccine
US10799575B2 (en) * 2015-06-25 2020-10-13 Technovax, Inc. Flavivirus and alphavirus virus-like particles (VLPS)
EP3184119A1 (en) * 2015-12-23 2017-06-28 Themis Bioscience GmbH Chromatography based purification strategies for measles scaffold based viruses
EP3412307A1 (en) * 2017-06-07 2018-12-12 Institut Pasteur Recombinant measles virus expressing zika virus proteins and their applications

Similar Documents

Publication Publication Date Title
JP2020524496A5 (enExample)
Bankamp et al. Genetic characterization of measles vaccine strains
RU2733832C1 (ru) Искусственный ген Stbl_RBD_TrM_SC2, кодирующий бицистронную структуру, образованную последовательностями рецепторсвязывающего домена гликопротеина S коронавируса SARS-CoV-2, трансмембранного региона, P2A-пептида и гликопротеина G VSV, рекомбинантная плазмида pStem-rVSV-Stbl_RBD_TrM_SC2, обеспечивающая экспрессию искусственного гена, и рекомбинантный штамм вируса везикулярного стоматита rVSV-Stbl_RBD_TrM_SC2, используемый для создания вакцины против коронавируса SARS-CoV-2
JP4608210B2 (ja) キメラアルファウイルスレプリコン粒子
RU2733834C1 (ru) Искусственный ген EctoS_SC2, кодирующий эктодомен гликопротеина S коронавируса SARS-CoV-2 с C-концевым тримеризующим доменом, рекомбинантная плазмида pStem-rVSV-EctoS_SC2, обеспечивающая экспрессию искусственного гена, и рекомбинантный штамм вируса везикулярного стоматита rVSV-EctoS_SC2, используемый для создания вакцины против коронавируса SARS-CoV-2
CN116472279A (zh) 麻疹载体covid-19免疫原性组合物和疫苗
AU2013322635B2 (en) Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
Skiadopoulos et al. Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp 45) human parainfluenza virus 3 candidate vaccine
JP2005515755A5 (enExample)
EP1375512A1 (en) Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions
JP2023107780A (ja) ジカウイルスタンパク質を発現する組換え麻疹ウイルス及びその適用
JP2023525785A (ja) 安定化コロナウイルススパイクタンパク質をコードするｒｎａレプリコン
Atasheva et al. Pseudoinfectious Venezuelan equine encephalitis virus: a new means of alphavirus attenuation
Zhang et al. Two polar residues within C‐terminal domain of M 1 are critical for the formation of influenza A Virions
CN115725657A (zh) 一种节段化的水泡性口炎病毒载体及其制备方法和应用
JP2011507514A5 (enExample)
TWI413691B (zh) 黃病毒重組體及其應用
CN106755089A (zh) 表达山羊淋巴细胞活化分子的细胞系及其构建方法与应用
Balamurugan et al. Past and present vaccine development strategies for the control of foot-and-mouth disease
US20160120974A1 (en) Semi-live respiratory syncytial virus vaccine
EP3865180A1 (en) Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses
EP2813574A1 (en) Semi-live respiratory syncytial virus vaccine
Mohan et al. Mutations selected in rotavirus enterotoxin NSP4 depend on the context of its expression
JPWO2019123018A5 (enExample)
CN119158007A (zh) 表达白细胞介素-15和白细胞介素-18的重组prrsv基因工程活载体疫苗及其应用